Daesang expands into biopharmaceuticals using 70 years of fermentation tech

Daesang expands into biopharmaceuticals using 70 years of fermentation tech

South Korean company Daesang expanded its operations into the global biopharmaceutical sector, leveraging seven decades of proprietary fermentation technology to manufacture high-purity medical-grade amino acids.
Reveillon Creations launches media platform connecting Malaysian talent to China

Reveillon Creations launches media platform connecting Malaysian talent to China

Reveillon Creations launched a media platform designed to provide commercial infrastructure, talent management services, and monetization pathways for Malaysian livestreamers entering China's creator economy.
Baseus launches fast-charging power ecosystem for iPhone Duo devices

Baseus launches fast-charging power ecosystem for iPhone Duo devices

Baseus introduced its power ecosystem designed for iPhone Duo devices, incorporating the PicoGo Air magnetic power bank and AH22 100W digital display fast charger.
Kazia Therapeutics doses first patient in paediatric brain cancer trial

Kazia Therapeutics doses first patient in paediatric brain cancer trial

Kazia Therapeutics initiated dosing in its PNOC035 clinical study evaluating drug candidate paxalisib alongside gemcitabine for children and young adults with recurrent AT/RT brain cancer.
Transcenta partners with WuXi Biologics to commercialise bioprocessing technology

Transcenta partners with WuXi Biologics to commercialise bioprocessing technology

Transcenta Therapeutics partnered with WuXi Biologics under a strategic agreement to accelerate the commercialisation and deployment of its proprietary HiCB continuous bioprocessing manufacturing technologies.
HR Path acquires tts digital HR experts to expand SAP consulting

HR Path acquires tts digital HR experts to expand SAP consulting

Human resources provider HR Path acquired tts digital HR experts GmbH to expand its consulting capabilities, technical implementation, and application management services for SAP SuccessFactors software.
Sceye completes 30,000 km stratospheric flight testing direct-to-device coverage

Sceye completes 30,000 km stratospheric flight testing direct-to-device coverage

Sceye completed a 30-day, 30,000-kilometre stratospheric flight between the United States and Japan, successfully verifying direct-to-device mobile connectivity alongside SoftBank Corporation.
LattePanda unveils micro compute module delivering 115 TOPS for AI

LattePanda unveils micro compute module delivering 115 TOPS for AI

LattePanda launched its Mu Ultra compute module featuring Intel Core Ultra processors, delivering up to 115 TOPS of artificial intelligence processing performance in a compact form factor.
Solstice Oncology secures $225 million series A for immuno-oncology therapy

Solstice Oncology secures $225 million series A for immuno-oncology therapy

Harbour BioMed partner Solstice Oncology secured $225 million in Series A financing to advance porustobart, a novel neoadjuvant immuno-oncology therapy targeting diverse cancer treatments.
Triple Whale repositions core brand as ecommerce AI operating system

Triple Whale repositions core brand as ecommerce AI operating system

Triple Whale unveiled a rebranded identity marking its operational transition from an e-commerce analytics platform into an integrated AI operating system for modern commercial enterprises.
Accely names Michael Lim regional strategy director for Southeast Asia

Accely names Michael Lim regional strategy director for Southeast Asia

SAP Gold Partner Accely appointed Michael Lim as Director of Strategy and Growth for Singapore and Southeast Asia to manage regional commercial strategy and corporate expansion.
Pexar launches Thunderbolt 5 dock featuring integrated display screen

Pexar launches Thunderbolt 5 dock featuring integrated display screen

Pexar introduced the PexarBolt Ultra TBT5 Dock equipped with a 5-inch visual dashboard, 10GbE network port, CFexpress Type B slot, and dedicated solid-state drive bay.
Alebund Pharmaceuticals receives FDA clearance for kidney disease trial

Alebund Pharmaceuticals receives FDA clearance for kidney disease trial

Alebund Pharmaceuticals received U.S. Food and Drug Administration investigational new drug clearance to commence clinical trials for AP308, targeting treatment of IgA nephropathy kidney disease.
|< < 1 2 3 4 > >|